Email

nxjanzen@texaschildrens.org

Positions

Assistant Professor

Urology
Baylor College of Medicine
Houston, TX, US

Addresses

Texas Children’s Hospital (Clinic)

Clinical Care Center
Houston, TX, 77030
United States
Phone: (832) 822-3160

Education

BA from Northwestern University, College of Arts and Science

01/1992 - Evanston, Illinois, United States

M.D. from Cornell University Medical College

01/1999 - New York, NY, United States

Residency at University of California, Los Angeles

06/2005 - Los Angeles, California, United States

Urology

Fellowship at Baylor College of Medicine

07/2007 - Houston, Texas, United States

Pediatric Urology

Certifications

American Board of Urology

Honors & Awards

Valentine Essay Contest

Second Place in Clinical Research Category; Resident Research Contest

New York Section of the American Urological Association Annual (05/1999)

Scholars in Urology Award

Pfizer (06/2004)

Goodwin Teaching Award

UCLA Department of Urology (06/2004)

Professional Interests

• Pediatric Urology

Websites

Selected Publications

• Janzen NK, Han KR, Perry KT, Said JW, Schulam PG, Belldegrun AS. " Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. " J. Endourol.. 2005 May ; 19 (4) : 520-5.
  Pubmed PMID: 15910269.
• Mukouyama H, Janzen NK, Hernandez JM, Lam JS, Caliliw R, Wang AY, Figlin RA, Belldegrun AS, Zeng G. " Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9. " Clin. Cancer Res.. 2004 Feb 15; 10 (4) : 1421-9.
  Pubmed PMID: 14977845.
• Janzen NK, Perry KT, Schulam PG. " Laparoscopic radical nephrectomy and minimally invasive surgery for kidney cancer. " Cancer Treat. Res.. 2003 ; 116 : 99-117.
  Pubmed PMID: 14650828.
• Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA. " Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. " J. Urol.. 2005 May ; 173 (5) : 1496-501.
  Pubmed PMID: 15821467.
• Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. " Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. " J. Urol.. 2003 Dec ; 170 (6) : 2221-4.
  Pubmed PMID: 14634383.
• Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS. " Using protein expressions to predict survival in clear cell renal carcinoma. " Clin. Cancer Res.. 2004 Aug 15; 10 (16) : 5464-71.
  Pubmed PMID: 15328185.
• Janzen NK, Perry KT, Han KR, Kristo B, Raman S, Said JW, Belldegrun AS, Schulam PG. " The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. " J. Urol.. 2005 Apr ; 173 (4) : 1368-74.
  Pubmed PMID: 15758807.
• Perry K, Zisman A, Pantuck AJ, Janzen N, Schulam P, Belldegrun AS. " Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma. " Rev Urol. 2002 ; 4 (3) : 103-11.
  Pubmed PMID: 16985666.
• Janzen NK, Kim HL, Figlin RA, Belldegrun AS. " Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. " Urol. Clin. North Am.. 2003 Nov ; 30 (4) : 843-52.
  Pubmed PMID: 14680319.
• Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, Dorey FJ, Zisman A, Janzen NK, Mukouyama H, Figlin RA, Belldegrun AS. " TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. " J. Urol.. 2003 Mar ; 169 (3) : 899-903; discus.
  Pubmed PMID: 12576809.

Show 6 more publications

Memberships

South Central Section of the American Urological Association

Member

American Urological Association

Member

Texas Medical Association

Member

Skills

Clinical Interests

Reconstruction of the genitourinary tract, hypospadias, vesicoureteral reflux, ureteropelvic junction obstruction, laparoscopic and robotic surgery, urinary tract infection, and voiding dysfunction.